The clinical answer is no and here is why: Off-label prescribing carries additional risk prescribing Ozempic for weight loss uses a medication outside its licensed indication, removing the formal clinical and regulatory framework that governs the weight management use of semaglutide The doses are different Ozempics maximum dose for diabetes is 2mg
These results may also prompt reconsideration of whether a weight loss of 5% or more remains the optimal goal for the treatment of obesity, or whether treatment goals should be reconsidered in the context of the magnitude and quality (i.e., in terms of body composition) of weight loss, specific BMI or percentage body fat targets (rather than percentage weight change), and health effects
Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration
When triglycerides are over 500, you can actually see the fats in the serum when a tube of blood is drawn
However, the general risks associated with unlicensed weight loss preparations are well established
